Wei Ming Tang
Corporate Officer/Principal at Vivere Lifesciences Acquisition Corp.
Wei Ming Tang active positions
Companies | Position | Start | End |
---|---|---|---|
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Corporate Officer/Principal | - | - |
Career history of Wei Ming Tang
Former positions of Wei Ming Tang
Companies | Position | Start | End |
---|---|---|---|
I-MAB | Corporate Officer/Principal | 31/03/2018 | 30/03/2024 |
Hengrui Therapeutics, Inc. | Director/Board Member | 30/06/2015 | 31/03/2018 |
Corporate Officer/Principal | 30/06/2015 | 31/03/2018 | |
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 30/06/2011 | 30/06/2015 |
Shanghai Biochip Co., Ltd.
Shanghai Biochip Co., Ltd. BiotechnologyHealth Technology Shanghai Biochip Co., Ltd. (dba ShanghaiBio Corp.) performs specialty R&D services for global pharma/biotech companies. Situated on its own 10-acre campus in the heart of Shanghai's Zhangjiang Hi-Tech Park, China's Bio/Pharma Valley, ShanghaiBio operates in seven buildings totaling 220,000 SQF that contain offices and laboratories. Its labs provide GLP/GMP-compliant services and continually undergo rigorous internal and external QA audits. The scientific staff is chiefly home-grown talent trained by professionals schooled in western ways. The company was founded in August 2001 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 30/09/2010 | 30/06/2011 |
Training of Wei Ming Tang
Rutgers State University of New Jersey | Doctorate Degree |
Zhejiang University | Undergraduate Degree |
Chinese Academy of Sciences | Graduate Degree |
Statistics
International
United States | 4 |
China | 4 |
France | 2 |
Operational
Corporate Officer/Principal | 5 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
I-MAB | Health Technology |
Private companies | 4 |
---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Shanghai Biochip Co., Ltd.
Shanghai Biochip Co., Ltd. BiotechnologyHealth Technology Shanghai Biochip Co., Ltd. (dba ShanghaiBio Corp.) performs specialty R&D services for global pharma/biotech companies. Situated on its own 10-acre campus in the heart of Shanghai's Zhangjiang Hi-Tech Park, China's Bio/Pharma Valley, ShanghaiBio operates in seven buildings totaling 220,000 SQF that contain offices and laboratories. Its labs provide GLP/GMP-compliant services and continually undergo rigorous internal and external QA audits. The scientific staff is chiefly home-grown talent trained by professionals schooled in western ways. The company was founded in August 2001 and is headquartered in Shanghai, China. | Health Technology |
Hengrui Therapeutics, Inc. | |
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Wei Ming Tang
- Experience